Peru · Findings · Debarred / sanctioned abroad × US SEC issuer

BMY · SUB~ · PE · CONSORCIO BRISTOL MYERS SQUIBB PERU S.A. - PERUFARMA S.A.

Why it is here

Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'BRISTOL MYERS SQUIBB PHARMA ~0.80' «CONSORCIO BRISTOL MYERS SQUIBB PERU S.A. - PERUFARMA S.A.» ↔ SEC BMY (CIK 14272, BRISTOL MYERS SQUIBB CO): 4 non-competitive contracts at the buyer «IAFAS DEL EJERCITO DEL PERU (FOSPEME)», 1,133,718 PEN (≈ $306,104); one bid, method direct (Contratación Directa); OCID ocds-dgv273-seacev3-753872, ocds-dgv273-seacev3-1016643, ocds-dgv273-seacev3-1030786, ocds-dgv273-seacev3-950116; ⚑ REPEAT: already sanctioned SEC by FCPA (2015-10-05 Bristol-Myers Squibb); buyer — security/fiscal body.

Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.

Details

Company / subject: BMY · SUB~ · PE · CONSORCIO BRISTOL MYERS SQUIBB PERU S.A. - PERUFARMA S.A.
Indicator: Debarred / sanctioned abroad × US SEC issuer
Amount: 306,104
Records behind the indicator: 4
Found: 4 October 2026
Code: W-02147
Reference: ocds-dgv273-seacev3-753872
Reference: ocds-dgv273-seacev3-1016643
Reference: ocds-dgv273-seacev3-1030786
Reference: ocds-dgv273-seacev3-950116
Reference: 2015-10-05

Other records of this company10

JSON Findings · Debarred / sanctioned abroad × US SEC issuer